Perelman School of Medicine at the University of Pennsylvania

Translate:
  • We study innovative fungi-based asbestos remediation strategies.

    We study innovative fungi-based asbestos remediation strategies.

  • We are developing a blood test for asbestos exposure.

    We are developing a blood test for asbestos exposure.

  • Occupational and non-occupational asbestos exposures will be examined.

    Occupational and non-occupational asbestos exposures will be examined.

  • We study ways to prevent mesothelioma.

    We study ways to prevent mesothelioma.

  • Our studies are driven by community-based concerns about asbestos waste.

    Our studies are driven by community-based concerns about asbestos waste.

Penn SRP Center funded by NIEHS for 4 Years

Researchers at the Center of Excellence in Environmental Toxicology (CEET), Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences (NIEHS) over the next four years to study asbestos exposure pathways that lead to asbestos-related diseases.

The Penn Superfund Research and Training Program (SRP) Center, which was established by this grant, evolved as a direct consequence of concerns from the community living near the BoRit Asbestos Superfund site in Ambler, PA, about 20 miles north of Philadelphia.

CEET is the academic home of the Penn SRP Center. Ian A. Blair, PhD, Professor of Pharmacology, is the director of the Center. CEET director, Trevor M. Penning, PhD, Professor of Pharmacology, is the deputy director of the Center. Christine Shwed is the Center's administrative program coordinator. Researchers from the Abramson Cancer Center (ACC), the Penn School of Arts and Sciences, and Fox Chase Cancer Center are also lead investigators on this grant.